Latest Insider Transactions at Avidity Biosciences, Inc. (RNA)
This section provides a real-time view of insider transactions for Avidity Biosciences, Inc. (RNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Avidity Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Avidity Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 12
2024
|
Michael F Mac Lean Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
104,245
-70.28%
|
$3,648,575
$35.72 P/Share
|
|
Jun 12
2024
|
Michael F Mac Lean Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
104,245
+41.27%
|
$833,960
$8.82 P/Share
|
|
Jun 12
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Indirect |
40,000
-15.76%
|
$1,400,000
$35.07 P/Share
|
|
Jun 12
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
100,000
-47.14%
|
$3,500,000
$35.73 P/Share
|
|
Jun 12
2024
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+32.04%
|
$100,000
$1.24 P/Share
|
|
Jun 04
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
28,000
-19.98%
|
$756,000
$27.42 P/Share
|
|
Jun 04
2024
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,000
+16.66%
|
$28,000
$1.24 P/Share
|
|
May 20
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
5,000
-25.21%
|
$145,000
$29.9 P/Share
|
|
May 20
2024
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.14%
|
$5,000
$1.24 P/Share
|
|
May 14
2024
|
Michael F Mac Lean Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
75,000
-62.98%
|
$2,100,000
$28.28 P/Share
|
|
May 14
2024
|
Michael F Mac Lean Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+38.64%
|
$600,000
$8.82 P/Share
|
|
May 07
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
28,000
-19.98%
|
$700,000
$25.54 P/Share
|
|
May 07
2024
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,000
+16.66%
|
$28,000
$1.24 P/Share
|
|
Apr 19
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
5,000
-25.21%
|
$110,000
$22.82 P/Share
|
|
Apr 19
2024
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.14%
|
$5,000
$1.24 P/Share
|
|
Apr 03
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Indirect |
20,000
-7.3%
|
$540,000
$27.11 P/Share
|
|
Apr 02
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
28,000
-19.98%
|
$728,000
$26.25 P/Share
|
|
Apr 02
2024
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,000
+16.66%
|
$28,000
$1.24 P/Share
|
|
Mar 19
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
5,000
-25.21%
|
$115,000
$23.97 P/Share
|
|
Mar 19
2024
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.14%
|
$5,000
$1.24 P/Share
|
|
Mar 13
2024
|
Michael F Mac Lean Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
40,000
-47.57%
|
$960,000
$24.52 P/Share
|
|
Mar 13
2024
|
Michael F Mac Lean Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+32.23%
|
$320,000
$8.82 P/Share
|
|
Mar 12
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
27,641
-36.99%
|
$608,102
$22.02 P/Share
|
|
Mar 12
2024
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+37.05%
|
$25,000
$1.24 P/Share
|
|
Mar 12
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
28,000
-19.98%
|
$616,000
$22.63 P/Share
|
|
Mar 12
2024
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,000
+16.66%
|
$28,000
$1.24 P/Share
|
|
Mar 08
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
84,000
-42.83%
|
$1,764,000
$21.39 P/Share
|
|
Mar 08
2024
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
84,000
+29.99%
|
$84,000
$1.24 P/Share
|
|
Mar 01
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
84,000
-42.83%
|
$1,680,000
$20.13 P/Share
|
|
Mar 01
2024
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
84,000
+29.99%
|
$84,000
$1.24 P/Share
|
|
Jan 22
2024
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
1,859
-9.62%
|
$18,590
$10.13 P/Share
|
|
Jan 22
2024
|
Michael F Mac Lean Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,616
-8.74%
|
$16,160
$10.13 P/Share
|
|
Jan 22
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
2,065
-10.81%
|
$20,650
$10.13 P/Share
|
|
Jan 22
2024
|
W. Michael Flanagan CSTO |
SELL
Open market or private sale
|
Direct |
4,129
-10.32%
|
$41,290
$10.13 P/Share
|
|
Jan 22
2024
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
5,092
-10.37%
|
$50,920
$10.13 P/Share
|
|
Jan 20
2024
|
Michael F Mac Lean Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,500
+45.26%
|
-
|
|
Jan 20
2024
|
Teresa Mc Carthy Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,500
+48.59%
|
-
|
|
Jan 20
2024
|
W. Michael Flanagan CSTO |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+49.64%
|
-
|
|
Jan 20
2024
|
Sarah Boyce President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
62,500
+48.18%
|
-
|
|
Dec 12
2023
|
Troy Edward Wilson Director |
BUY
Other acquisition or disposition
|
Indirect |
550,000
+47.73%
|
-
|
|
Dec 12
2023
|
Troy Edward Wilson Director |
SELL
Other acquisition or disposition
|
Indirect |
550,000
-74.01%
|
-
|
|
Mar 15
2023
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
100
-0.51%
|
$2,200
$22.01 P/Share
|
|
Mar 15
2023
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.51%
|
$100
$1.24 P/Share
|
|
Feb 14
2023
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
10,000
-17.47%
|
$230,000
$23.93 P/Share
|
|
Feb 14
2023
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+25.43%
|
$10,000
$1.24 P/Share
|
|
Feb 03
2023
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
3,221
-5.69%
|
$77,304
$24.26 P/Share
|
|
Feb 03
2023
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,221
+5.39%
|
$3,221
$1.24 P/Share
|
|
Feb 02
2023
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
45,879
-46.23%
|
$1,101,096
$24.36 P/Share
|
|
Feb 02
2023
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
45,879
+31.62%
|
$45,879
$1.24 P/Share
|
|
Feb 01
2023
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
900
-1.66%
|
$21,600
$24.27 P/Share
|